Two Sigma Advisers’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$118K Sell
30,800
-2,300
-7% -$8.81K ﹤0.01% 2191
2025
Q1
$190K Sell
33,100
-92,200
-74% -$530K ﹤0.01% 2151
2024
Q4
$625K Sell
125,300
-84,000
-40% -$419K ﹤0.01% 1687
2024
Q3
$1.13M Sell
209,300
-73,600
-26% -$397K ﹤0.01% 1358
2024
Q2
$936K Sell
282,900
-92,000
-25% -$305K ﹤0.01% 1583
2024
Q1
$1.23M Buy
374,900
+23,500
+7% +$76.8K ﹤0.01% 1473
2023
Q4
$1.23M Sell
351,400
-69,500
-17% -$244K ﹤0.01% 1537
2023
Q3
$2.81M Sell
420,900
-13,100
-3% -$87.5K 0.01% 1013
2023
Q2
$3.64M Sell
434,000
-93,900
-18% -$788K 0.01% 902
2023
Q1
$5.24M Sell
527,900
-62,200
-11% -$618K 0.01% 789
2022
Q4
$4.11M Sell
590,100
-307,500
-34% -$2.14M 0.01% 862
2022
Q3
$4.79M Buy
897,600
+10,600
+1% +$56.6K 0.01% 755
2022
Q2
$3.54M Buy
887,000
+379,300
+75% +$1.51M 0.01% 922
2022
Q1
$2.26M Sell
507,700
-181,500
-26% -$807K 0.01% 1186
2021
Q4
$2.76M Sell
689,200
-99,200
-13% -$397K 0.01% 1033
2021
Q3
$6.92M Sell
788,400
-227,100
-22% -$1.99M 0.02% 645
2021
Q2
$11.5M Buy
1,015,500
+180,100
+22% +$2.04M 0.03% 510
2021
Q1
$9.93M Buy
835,400
+162,100
+24% +$1.93M 0.03% 577
2020
Q4
$4.62M Buy
673,300
+72,700
+12% +$499K 0.01% 856
2020
Q3
$4.45M Buy
600,600
+523,600
+680% +$3.88M 0.01% 805
2020
Q2
$321K Buy
77,000
+42,700
+124% +$178K ﹤0.01% 2098
2020
Q1
$85K Buy
34,300
+24,200
+240% +$60K ﹤0.01% 2317
2019
Q4
$59K Buy
+10,100
New +$59K ﹤0.01% 2286